{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:43:01Z","timestamp":1765546981287},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,15]]},"DOI":"10.7759\/cureus.31519","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T08:13:08Z","timestamp":1668499988000},"source":"Crossref","is-referenced-by-count":3,"title":["A Rare Case of Rhabdomyolysis"],"prefix":"10.7759","author":[{"given":"Francisco","family":"Pombo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Dalila","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindora","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres PA","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015, 15:58-69.","journal-title":"Ochsner J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205127","article-title":"Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort","volume":"74","author":"Dobloug C","year":"2015","unstructured":"Dobloug C, Garen T, Bitter H, et al.. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis. 2015, 74:1551-6. 10.1136\/annrheumdis-2013-205127","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew503","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study","volume":"56","author":"Svensson J","year":"2017","unstructured":"Svensson J, Arkema EV, Lundberg IE, Holmqvist M. Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study. Rheumatology (Oxford). 2017, 56:802-10. 10.1093\/rheumatology\/kew503","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020, 16:689-701. 10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez I","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018, 20:21. 10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito P","year":"2010","unstructured":"Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve. 2010, 41:185-90. 10.1002\/mus.21486","journal-title":"Muscle Nerve"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7963","article-title":"Statin-induced immune-mediated necrotizing myopathy: an increasingly recognized inflammatory myopathy","volume":"12","author":"Stroie OP","year":"2020","unstructured":"Stroie OP, Boster J, Surry L. Statin-induced immune-mediated necrotizing myopathy: an increasingly recognized inflammatory myopathy. Cureus. 2020, 12:e7963. 10.7759\/cureus.7963","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac144","article-title":"Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluation","author":"Shelly S","year":"2022","unstructured":"Shelly S, Beecher G, Milone M, et al.. Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluation. Rheumatology (Oxford). 2022, keac144. 10.1093\/rheumatology\/keac144","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27824","article-title":"Seronegative immune-mediated necrotizing myopathy: a case report","volume":"14","author":"Patel S","year":"2022","unstructured":"Patel S, Abu-Abaa M, Mousavi F. Seronegative immune-mediated necrotizing myopathy: a case report. Cureus. 2022, 14:e27824. 10.7759\/cureus.27824","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7827","article-title":"Autoantibody-negative immune-mediated necrotizing myopathy responds to early and aggressive treatment: a case report","volume":"12","author":"Marotta DA","year":"2020","unstructured":"Marotta DA, Zadourian A, Jabaay MJ, Kesserwani A, Kesserwani H. Autoantibody-negative immune-mediated necrotizing myopathy responds to early and aggressive treatment: a case report. Cureus. 2020, 12:e7827. 10.7759\/cureus.7827","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236603","article-title":"Fulminant immune-mediated necrotising myopathy (IMNM) mimicking myocardial infarction with non-obstructive coronary arteries (MINOCA)","volume":"13","author":"Glenn-Cox S","year":"2020","unstructured":"Glenn-Cox S, Foley RW, Pauling JD, Rodrigues JC. Fulminant immune-mediated necrotising myopathy (IMNM) mimicking myocardial infarction with non-obstructive coronary arteries (MINOCA). BMJ Case Rep. 2020, 13:e236603. 10.1136\/bcr-2020-236603","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2021.1885091","article-title":"Seronegative necrotizing autoimmune myopathy with favorable response to intravenous immunoglobulin","volume":"34","author":"Liu R","year":"2021","unstructured":"Liu R, Fenves AZ, Champion SN, Dau J. Seronegative necrotizing autoimmune myopathy with favorable response to intravenous immunoglobulin. Proc (Bayl Univ Med Cent). 2021, 34:481-3. 10.1080\/08998280.2021.1885091","journal-title":"Proc (Bayl Univ Med Cent)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/123892-a-rare-case-of-rhabdomyolysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:25Z","timestamp":1707508225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/123892-a-rare-case-of-rhabdomyolysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.31519","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,15]]}}}